10x Genomics (Nasdaq: TXG) Xenium Powers ASTRA Atlas of 2,000 Asia-Pacific Tumor Samples - Stock Titan
#Xenium Powers#Stock Titan#Powers ASTRA#ASTRA Atlas#Asia-Pacific Tumor
Life Science News
Latest updates from the biotech and pharma world
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium - PR Newswire
#Genomics' Xenium#ASTRA Consortium#Consortium Unites#Spatial Atlas#Atlas Powered
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq
#Price Target#Target Increased#Genomics#TXG#Nasdaq
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
#Genomics Expands#Expands Flex#Flex Lineup#Assay Launch#Single-Cell Assay
10x Genomics (TXG): Assessing Valuation After Recent 34% Share Price Rise - simplywall.st
#Assessing Valuation#Share Price#Price Rise#Genomics#TXG
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - Yahoo Finance
#Genomics Expands#Yahoo Finance#Expands Flex#Flex Lineup#Assay Launch
10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360
#Led Rule#Law Effort#Genomics#Led#Rule
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st
#Price Jump#Genomics#Inc.#NASDAQ#TXG
10x Genomics Announces Chief Legal Officer Retirement - TipRanks
#Genomics Announces#Announces Chief#Chief Legal#Legal Officer#Officer Retirement
10x Genomics brings natural language to single-cell analysis through Claude integration - R&D World
#Genomics brings#Claude integration#brings natural#natural language#single-cell analysis
10x Genomics on the “last mile” problem in single-cell analysis - R&D World
#single-cell analysis#Genomics#World#mile#problem
10x Genomics (NASDAQ:TXG) Nasdaq Futures Drives Data Biology - Kalkine Media
#Nasdaq Futures#Kalkine Media#Futures Drives#Drives Data#Data Biology
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call - Markets Financial Content
#Insightful Analyst#Financial Content#Earnings Call#Analyst Questions#Markets Financial
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call - Markets Financial Content
#Insightful Analyst#Financial Content#Earnings Call#Analyst Questions#Markets Financial
10x Genomics (TXG): Assessing Valuation After Strong Earnings, Upbeat Forecast and New Product Launch - Yahoo Finance
#Assessing Valuation#Strong Earnings#Upbeat Forecast#Yahoo Finance#Product Launch
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call - Yahoo Finance
#Insightful Analyst#Earnings Call#Yahoo Finance#Analyst Questions#Call Yahoo
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
#Sandler Maintains#Neutral Recommendation#Piper Sandler#Recommendation Nasdaq#Genomics
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - MSN
#Net Loss#Revenue Beat#Record High#Lower Net#Beat MSN
Why 10x Genomics (TXG) Stock Is Trading Up Today - Markets Financial Content
#Markets Financial#Financial Content#Today Markets#Genomics#TXG
Is 10x Genomics Inc. stock ready for a breakout - Weekly Market Summary & AI Enhanced Trading Signals - newser.com
#Weekly Market#Market Summary#Enhanced Trading#Trading Signals#Genomics